{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:35:35Z","timestamp":1792794935094,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00296-020-04627-z","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T20:03:49Z","timestamp":1592856229000},"page":"1529-1536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical presentation, imaging and response to interferon-alpha therapy in Erdheim\u2013Chester disease: case-based review"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2095-5819","authenticated-orcid":false,"given":"Oleg","family":"Iaremenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8330-8681","authenticated-orcid":false,"given":"Liubov","family":"Petelytska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9912-4286","authenticated-orcid":false,"given":"Olena","family":"Dyadyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8643-6371","authenticated-orcid":false,"given":"Nataliia","family":"Negria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7965-9438","authenticated-orcid":false,"given":"Dmytro","family":"Fedkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"key":"4627_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00005792-199605000-00005","volume":"75","author":"C Veyssier-Belot","year":"1996","unstructured":"Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D et al (1996) Erdheim-Chester disease: clinical and radiologic characteristics of 59 cases. Medicine 75:157\u2013169. https:\/\/doi.org\/10.1097\/00005792-199605000-00005","journal-title":"Medicine"},{"issue":"4","key":"4627_CR2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","volume":"124","author":"E Diamond","year":"2014","unstructured":"Diamond E, Dagna L, Hyman D, Cavalli G, Janku F et al (2014) Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood 124(4):483\u2013492. https:\/\/doi.org\/10.1182\/blood-2014-03-561381","journal-title":"Blood"},{"key":"4627_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11926-019-0865-2","volume":"21","author":"M Papo","year":"2019","unstructured":"Papo M, Emile JF, Maciel TT et al (2019) Erdheim-Chester Disease: a concise review. Curr Rheumatol Rep 21:66. https:\/\/doi.org\/10.1007\/s11926-019-0865-2","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"4627_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ejim.2015.03.004","volume":"26","author":"C Campochiaro","year":"2015","unstructured":"Campochiaro C, Tomelleri A, Cavalli G, Berti A, Dagna L (2015) Erdheim-Chester disease. Eur J Internal Med 26(4):223\u2013229. https:\/\/doi.org\/10.1016\/j.ejim.2015.03.004","journal-title":"Eur J Internal Med"},{"issue":"10","key":"4627_CR5","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1182\/blood-2010-06-294108","volume":"117","author":"L Arnaud","year":"2011","unstructured":"Arnaud L, Hervier B, Neel A et al (2011) CNS involvement and treatment with interferon-alpha are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood 117(10):2778\u20132782. https:\/\/doi.org\/10.1182\/blood-2010-06-294108","journal-title":"Blood"},{"key":"4627_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s002560050351","volume":"27","author":"L Bancroft","year":"1998","unstructured":"Bancroft L, Berquist T (1998) Erdheim-Chester disease: radiographic findings in five patients. Skeletal Radiol 27:127\u2013132. https:\/\/doi.org\/10.1007\/s002560050351","journal-title":"Skeletal Radiol"},{"issue":"4","key":"4627_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s13244-014-0331-7","volume":"5","author":"C Antunes","year":"2014","unstructured":"Antunes C, Gra\u00e7a B, Donato P (2014) Thoracic, abdominal and musculoskeletal involvement in Erdheim-Chester disease: CT, MR and PET imaging findings. Insights Imaging 5(4):473\u2013482. https:\/\/doi.org\/10.1007\/s13244-014-0331-7","journal-title":"Insights Imaging"},{"key":"4627_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12519-010-0205-0","volume":"6","author":"J Wang","year":"2010","unstructured":"Wang J, Wu X, Xi ZJ (2010) Langerhans cell histiocytosis of bone in children: a clinicopathologic study of 108 cases. World J Pediatr 6:255\u2013259. https:\/\/doi.org\/10.1007\/s12519-010-0205-0","journal-title":"World J Pediatr"},{"key":"4627_CR9","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00247-016-3594-y","volume":"46","author":"TV White","year":"2016","unstructured":"White TV, Silvester NC, Otero HJ (2016) Non-sclerotic bone involvement in Erdheim\u2013Chester: PET\/CT and MRI findings in a 15-year-old boy. Pediatr Radiol 46:1345\u20131349. https:\/\/doi.org\/10.1007\/s00247-016-3594-y","journal-title":"Pediatr Radiol"},{"key":"4627_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00256-004-0846-y","volume":"34","author":"CU Joo","year":"2005","unstructured":"Joo CU, Go YS, Kim IH et al (2005) Erdheim-Chester disease in a child with MR imaging showing regression of marrow changes. Skeletal Radiol 34:299. https:\/\/doi.org\/10.1007\/s00256-004-0846-y","journal-title":"Skeletal Radiol"},{"issue":"3","key":"4627_CR11","first-page":"410","volume":"32","author":"G Moulis","year":"2014","unstructured":"Moulis G, Sailler L, Bonneville F, Wagner T (2014) Imaging in Erdheim-Chester disease: classic features and new insights. Clin Exp Rheumatol 32(3):410\u2013414 (Epub 2014 Jan 14)","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"4627_CR12","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.semarthrit.2011.11.004","volume":"41","author":"B Hervier","year":"2012","unstructured":"Hervier B, Arnaud L, Charlotte F, Wechsler B, Piette JC, Amoura Z, Haroche J (2012) Treatment of Erdheim-Chester disease with long-term high-dose interferon-\u03b1. Semin Arthritis Rheum 41(6):907\u2013913. https:\/\/doi.org\/10.1016\/j.semarthrit.2011.11.004 (Epub 2012 Jan 31)","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"4627_CR13","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1182\/blood-2017-03-771873","volume":"130","author":"F Cohen Aubart","year":"2017","unstructured":"Cohen Aubart F, Emile J-F, Carrat F, Charlotte F, Benameur N, Donadieu J et al (2017) Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study). Blood 130(11):1377\u20131380. https:\/\/doi.org\/10.1182\/blood-2017-03-771873","journal-title":"Blood"},{"key":"4627_CR14","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMoa1502309","volume":"373","author":"DM Hyman","year":"2015","unstructured":"Hyman DM, Puzanov I, Subbiah V, Faris JE, Chau I, Blay J-Y et al (2015) Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations. N Engl J Med 373:726\u2013736. https:\/\/doi.org\/10.1056\/NEJMoa1502309","journal-title":"N Engl J Med"},{"issue":"3","key":"4627_CR15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1001\/jamaoncol.2017.5029","volume":"4","author":"EL Diamond","year":"2018","unstructured":"Diamond EL, Subbiah V, Lockhart AC et al (2018) Vemurafenib for BRAF V600\u2013Mutant Erdheim-Chester disease and langerhans cell histiocytosis: analysis of data from the histology-independent, phase 2, Open-label VE-BASKET Study. JAMA Oncol 4(3):384\u2013388. https:\/\/doi.org\/10.1001\/jamaoncol.2017.5029","journal-title":"JAMA Oncol"},{"key":"4627_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41586-019-1012-y","volume":"567","author":"EL Diamond","year":"2019","unstructured":"Diamond EL, Durham BH, Ulaner GA et al (2019) Efficacy of MEK inhibition in patients with histiocytic neoplasms. Nature 567:521\u2013524. https:\/\/doi.org\/10.1038\/s41586-019-1012-y","journal-title":"Nature"},{"issue":"11","key":"4627_CR17","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1182\/blood-2015-09-672667","volume":"127","author":"F Cohen-Aubart","year":"2016","unstructured":"Cohen-Aubart F, Maksud P, Saadoun D, Drier A, Charlotte F, Cluzel P et al (2016) Variability in the efficacy of the IL1 receptor antagonist anakinra for treating Erdheim-Chester disease. Blood 127(11):1509\u20131512. https:\/\/doi.org\/10.1182\/blood-2015-09-672667","journal-title":"Blood"},{"key":"4627_CR18","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/bjh.14997","volume":"183","author":"G Goyal","year":"2018","unstructured":"Goyal G, Shah MV, Call TG, Litzow MR, Wolanskyj-Spinner AP, Koster MJ et al (2018) Efficacy of biological agents in the treatment of Erdheim-Chester disease. Br J Haematol 183:520\u2013524. https:\/\/doi.org\/10.1111\/bjh.14997","journal-title":"Br J Haematol"},{"key":"4627_CR19","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1136\/annrheumdis-2017-212678","volume":"77","author":"F Cohen-Aubart","year":"2018","unstructured":"Cohen-Aubart F, Maksud P, Emile J-F, Benameur N, Charlotte F, Cluzel P et al (2018) Efficacy of infliximab in the treatment of Erdheim-Chester disease. Ann Rheum Dis 77:1387\u20131390. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212678","journal-title":"Ann Rheum Dis"},{"key":"4627_CR20","doi-asserted-by":"publisher","first-page":"e1318237","DOI":"10.1080\/2162402X.2017.1318237","volume":"6","author":"A Berti","year":"2017","unstructured":"Berti A, Cavalli G, Guglielmi B, Biavasco R, Campochiaro C, Tomelleri A et al (2017) Tocilizumab in patients with multisystem Erdheim-Chester disease. Oncoimmunology 6:e1318237. https:\/\/doi.org\/10.1080\/2162402X.2017.1318237","journal-title":"Oncoimmunology"},{"issue":"9","key":"4627_CR21","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1001\/jamaoncol.2017.0041","volume":"3","author":"G Goyal","year":"2017","unstructured":"Goyal G, Shah MV, Call TG, Litzow MR, Hogan WJ, Go RS (2017) Clinical and radiologic responses to cladribine for the treatment of Erdheim-Chester disease. JAMA Oncol 3(9):1253\u20131256. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0041","journal-title":"JAMA Oncol"},{"issue":"11","key":"4627_CR22","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"4627_CR23","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s11926-014-0412-0","volume":"16","author":"J Haroche","year":"2014","unstructured":"Haroche J, Arnaud L, Cohen-Aubart F et al (2014) Erdheim-Chester disease. Curr Rheumatol Rep 16:412. https:\/\/doi.org\/10.1007\/s11926-014-0412-0","journal-title":"Curr Rheumatol Rep"},{"key":"4627_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/1750-1172-8-137","volume":"8","author":"RD Mazor","year":"2013","unstructured":"Mazor RD, Manevich-Mazor M, Shoenfeld Y (2013) Erdheim-Chester disease: a comprehensive review of the literature. Orphanet J Rare Dis 8:137. https:\/\/doi.org\/10.1186\/1750-1172-8-137","journal-title":"Orphanet J Rare Dis"},{"key":"4627_CR25","unstructured":"Swerdlow SH, Campo E, Harris NL et al (2017)\u00a0Chapter 17: histiocytic and dendritic cell neoplasms. In: Swerdlow SH, Campo E, Harris NL, et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues\u00a0(Revised 4th Edition). International Agency for Research on Cancer, Lyon, pp 465\u2013482"},{"issue":"1","key":"4627_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2015.02.004","volume":"95","author":"M Cives","year":"2015","unstructured":"Cives M, Simone V, Rizzo FM et al (2015) Erdheim-Chester disease: a systematic review. Crit Rev Oncol Hematol 95(1):1\u201311. https:\/\/doi.org\/10.1016\/j.critrevonc.2015.02.004","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"4627_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.critrevonc.2015.02.004","volume":"2","author":"JP Neckman","year":"2015","unstructured":"Neckman JP, Kim J, Mathur M et al (2015) Diverse cutaneous manifestations of Erdheim-Chester disease in a woman with a history of Langerhans cell histiocytosis Neckman, Julia Pettersen et al. JAAD case reports. Clin Rev Oncol Hematol 2(2):128\u2013131. https:\/\/doi.org\/10.1016\/j.critrevonc.2015.02.004","journal-title":"Clin Rev Oncol Hematol"},{"key":"4627_CR28","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1600-0560.2010.01650","volume":"38","author":"ER Volpicelli","year":"2011","unstructured":"Volpicelli ER, Doyle L, Annes JP, Murray MF, Jacobsen E, Murphy GF, Saavedra AP (2011) Erdheim-Chester disease presenting with cutaneous involvement: a case report and literature review. J Cutan Pathol 38:280\u2013285. https:\/\/doi.org\/10.1111\/j.1600-0560.2010.01650","journal-title":"J Cutan Pathol"},{"key":"4627_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3171\/2009.10.SPINE09316","volume":"12","author":"AM Allmendinger","year":"2010","unstructured":"Allmendinger AM, Krauthamer AV, Spektor V, Aziz MS, Zablow B (2010) Atypical spine involvement of Erdheim-Chester disease in an elderly male. J Neurosurg Spine 12:257\u2013260. https:\/\/doi.org\/10.3171\/2009.10.SPINE09316","journal-title":"J Neurosurg Spine"},{"key":"4627_CR30","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.crad.2009.10.010","volume":"65","author":"AM Davies","year":"2010","unstructured":"Davies AM, Colley SP, James SL, Sumathi VP, Grimer RJ (2010) Erdheim-Chester disease presenting with destruction of a metacarpal. Clin Radiol 65:250\u2013253. https:\/\/doi.org\/10.1016\/j.crad.2009.10.010","journal-title":"Clin Radiol"},{"key":"4627_CR31","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1148\/radiol.2382041525","volume":"238","author":"E Dion","year":"2006","unstructured":"Dion E, Graef C, Miquel A, Haroche J, Wechsler B, Amoura Z, Zeitoun D, Grenier PA, Piette JC, Laredo JD (2006) Bone involvement in Erdheim-Chester disease: imaging findings including periostitis and partial epiphyseal involvement. Radiology 238:632\u2013639. https:\/\/doi.org\/10.1148\/radiol.2382041525","journal-title":"Radiology"},{"issue":"1","key":"4627_CR32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4103\/1450-1147.181149","volume":"16","author":"P Martineau","year":"2017","unstructured":"Martineau P, Pelletier-Galarneau M, Zeng W (2017) The Imaging Findings of Erdheim-Chester disease: a multimodality approach to diagnosis and staging. World J Nucl Med 16(1):71\u201374. https:\/\/doi.org\/10.4103\/1450-1147.181149","journal-title":"World J Nucl Med"},{"issue":"10","key":"4627_CR33","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1002\/art.24848","volume":"60","author":"L Arnaud","year":"2009","unstructured":"Arnaud L, Malek Z, Archambaud F et al (2009) 18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in follow up than in the initial assessment of patients with Erdheim-Chester disease. Arthritis Rheum 60(10):3128\u20133138. https:\/\/doi.org\/10.1002\/art.24848","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4627_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13023-018-0988-y","volume":"14","author":"XX Cao","year":"2019","unstructured":"Cao XX, Niu N, Sun J et al (2019) Clinical and positron emission tomography responses to long-term high-dose interferon-\u03b1 treatment among patients with Erdheim-Chester disease. Orphanet J Rare Dis 14(1):11. https:\/\/doi.org\/10.1186\/s13023-018-0988-y","journal-title":"Orphanet J Rare Dis"},{"issue":"20","key":"4627_CR35","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1182\/blood-2010-04-279240","volume":"116","author":"A Aouba","year":"2010","unstructured":"Aouba A, Georgin-Lavialle S, Pagnoux C, Martin SN, Renand A, Galateau-Salle F et al (2010) Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease. Blood 116(20):4070\u20134076. https:\/\/doi.org\/10.1182\/blood-2010-04-279240","journal-title":"Blood"},{"key":"4627_CR36","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1182\/blood-2005-06-2238","volume":"106","author":"F Braiteh","year":"2005","unstructured":"Braiteh F, Boxrud C, Esmaeli B, Kurzrock R (2005) Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-alpha. Blood 106:2992\u20132994. https:\/\/doi.org\/10.1182\/blood-2005-06-2238","journal-title":"Blood"},{"key":"4627_CR37","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1002\/art.22165","volume":"54","author":"J Haroche","year":"2006","unstructured":"Haroche J, Amoura Z, Trad SG, Wechsler B, Cluzel P, Grenier PA et al (2006) Variability in the efficacy of interferon-alpha in Erdheim-Chester disease by patient and site of involvement: results in eight patients. Arthritis Rheum 54:3330\u20133336. https:\/\/doi.org\/10.1002\/art.22165","journal-title":"Arthritis Rheum"},{"key":"4627_CR38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s10067-003-0801-7","volume":"23","author":"MC Jendro","year":"2004","unstructured":"Jendro MC, Zeidler H, Rosenthal H, Haller H, Schwarz A (2004) Improvement of Erdheim-Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil. Clin Rheumatol 23:52\u201356. https:\/\/doi.org\/10.1007\/s10067-003-0801-7","journal-title":"Clin Rheumatol"},{"key":"4627_CR39","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1136\/bjo.2003.035584","volume":"88","author":"C Myra","year":"2004","unstructured":"Myra C, Sloper L, Tighe PJ, McIntosh RS, Stevens SE, Gregson RH et al (2004) Treatment of Erdheim-Chester disease with cladribine: a rational approach. Br J Ophthalmol 88:844\u2013847. https:\/\/doi.org\/10.1136\/bjo.2003.035584","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"4627_CR40","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/DAD.0b013e3181f2bf06","volume":"33","author":"M Skinner","year":"2011","unstructured":"Skinner M, Briant M, Morgan MB (2011) Erdheim-Chester disease: a histiocytic disorder more than skin deep. Am J Dermatopathol 33(2):e24\u2013e26. https:\/\/doi.org\/10.1097\/DAD.0b013e3181f2bf06","journal-title":"Am J Dermatopathol"},{"key":"4627_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12916-014-0221-3","volume":"12","author":"RD Mazor","year":"2014","unstructured":"Mazor RD, Manevich-Mazor M, Kesler A et al (2014) Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series. BMC Med 12:221. https:\/\/doi.org\/10.1186\/s12916-014-0221-3","journal-title":"BMC Med"},{"issue":"4","key":"4627_CR42","doi-asserted-by":"publisher","first-page":"439","DOI":"10.5021\/ad.2010.22.4.439","volume":"22","author":"M-S Kim","year":"2010","unstructured":"Kim M-S, Kim C-H, Choi S-J et al (2010) Erdheim-Chester disease. Ann Dermatol 22(4):439\u2013443. https:\/\/doi.org\/10.5021\/ad.2010.22.4.439","journal-title":"Ann Dermatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04627-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04627-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04627-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T23:35:18Z","timestamp":1624318518000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04627-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["4627"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04627-z","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,22]]},"assertion":[{"value":"8 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Authors fulfilled the ICMJE authorship criteria.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Written informed consent was obtained from the patient prior to submission of this article for consideration as a case-based review.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}